Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03600649 |
Recruitment Status :
Active, not recruiting
First Posted : July 26, 2018
Last Update Posted : November 21, 2023
|
Sponsor:
Salarius Pharmaceuticals, LLC
Collaborator:
National Pediatric Cancer Foundation
Information provided by (Responsible Party):
Salarius Pharmaceuticals, LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | September 2025 |
Estimated Study Completion Date : | December 2025 |